Cidara Therapeutics Inc.

This study is testing whether a new long-acting antiviral drug called CD388 can prevent the flu in adults and adolescents who are at higher risk of serious complications. Participants receive either the drug or a placebo as three small injections under the skin. The main goal is …

This study is checking if it's safe to give a new, long-acting flu prevention medicine called CD388 at the same time as a high-dose flu vaccine. Researchers want to see if the drug interferes with the body's ability to build protection from the vaccine. About 100 healthy adults w…

This study aims to see if giving two annual doses of an experimental long-acting antiviral drug called CD388 is safe for healthy adults who tolerated it well in a previous study. Researchers will check if the body starts making antibodies against the drug after repeated doses, wh…